HMGB proteins (specifically HMGB1) are involved in the response to immunogenic cell death [55,56] occurring after RT, and HMGB2 is a known regulator of CD8+ T cells, required for anti-melanoma response [57]. This evidence concerns the gene HMGB2 and melanoma.